Sort
21,281 grants matching “influenza”
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,563,107Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2019 · AI
Defining New Human Immunodeficiency and Immunodysregulation Disorders
$1,561,977Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
University of Washington Vaccine and Treatment Evaluation Unit
$1,561,928Anna Wald · University Of Washington · UM1 · FY2022 · AI
Antigen Processing And Presentation In The Intestine
$1,561,593Brian Kelsall · Niaid Extramural Activities · Z01 · FY2007 · AI
Drivers of individual variation in influenza vaccine response and protection from infection
$1,561,514Sarah Cobey · University Of Chicago · R01 · FY2022 · AI
Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients
$1,561,471Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2017 · AI
Boston-Area Research Training Program in Biomedical Informatics
$1,561,223Lucila Ohno-Machado · Harvard Medical School · T15 · FY2007 · LM
Rapid point-of-care diagnostic for bioterrorism "A" agents and Pandemic influenza
$1,561,105Kelly J. Henrickson · Medical College Of Wisconsin · U01 · FY2008 · AI
Mass Spectrometry Resource for Biology and Medicine
$1,559,777Catherine E. Costello · Boston University Medical Campus · P41 · FY2015 · GM
Stanford/UNC Biomimetic U19 Research Center
$1,559,276Calvin J Kuo · Stanford University · U19 · FY2021 · AI
Facility Management, Maintenance and Operations Core
$1,559,213Sixto Manuel Leal · University Of Alabama At Birmingham · UC7 · FY2025 · AI
CFI Pathogen Inactivation of Human Plasma Units
$1,558,277Trevor P. Castor · Aphios Corporation · R44 · FY2019 · HL
Immunological responses to pan-CoV vaccines
$1,558,161Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2023 · AI
Clinical Interventional Studies of HIV Reservoirs
$1,557,495Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity
$1,557,469Mark E. Peeples · Research Inst Nationwide Children'S Hosp · P01 · FY2019 · AI
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection
$1,557,191Thomas J Braciale · University Of Virginia · U19 · FY2009 · AI
Research Initiatives on COVID-19 in the Division of the National Toxicology Program
$1,557,106Brian Berridge · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Manipulating natural host immunoregulation via IDO during viral Infection
$1,556,672Andrew Lee Mellor · Augusta University · U01 · FY2009 · AI
Develop, Optimize and Commercialize UltraMarathonRT: A new enzyme for unbiased transcriptomic and epitranscriptomic characterization of RNAs regardless of length or composition.
$1,555,946Li-Tao Guo · Rnaconnect Inc · R44 · FY2024 · GM
Vaccine and Treatment Evaluation Units (VTEU)
$1,555,829Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2022 · AI
EpiCenter for Emerging Infectious Disease Intelligence
$1,555,321Christine Kreuder Johnson · University Of California At Davis · U01 · FY2023 · AI
Clinical and Informatics Research on Large Clinical Databases
$1,554,491Clement McDonald · National Library Of Medicine · ZIA · FY2021 · LM
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses
$1,553,196Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Collaborative Influenza Vaccine Innovation Centers STATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC)
$1,552,723Stephan Bour · Digital Infuzion, Inc. · N01 · FY2023 · AI
Defining New Human Immunodeficiency and Immunodysregulation Disorders
$1,551,304Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI